Nojima, T., Matsubayashi, Y., Yoshida, A., Suganami, H., Abe, T., Ishizawa, M., . . . Sone, H. (2020). Influence of an SGLT2 inhibitor, tofogliflozin, on the resting heart rate in relation to adipose tissue insulin resistance. Diabet Med.
Citação norma ChicagoNojima, T., et al. "Influence of an SGLT2 Inhibitor, Tofogliflozin, On the Resting Heart Rate in Relation to Adipose Tissue Insulin Resistance." Diabet Med 2020.
MLA citiranjeNojima, T., et al. "Influence of an SGLT2 Inhibitor, Tofogliflozin, On the Resting Heart Rate in Relation to Adipose Tissue Insulin Resistance." Diabet Med 2020.
Opozorilo: Ti citati niso vedno 100% točni.